Study of Heat Shock Proteins as Prognostic Factor of Acute Renal Failure in Children (HSP-Study)
NCT ID: NCT00230412
Last Updated: 2010-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2005-10-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Impact of Pediatric Acute Renal Injury in Severe Sepsis
NCT02372721
Evaluation Of The Degree Of Kidney Injury in Children With Hypovolemic Shock
NCT06612073
Severe Sepsis in Children - IMPRESS-C
NCT02598674
Prospective Evaluation of Blunt Renal Injury in Children
NCT00855036
Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults
NCT02904863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ANR occurs in up to 50 percent of all critical ill patients and has a high rate of morbidity and mortality despite advances in symptomatic therapy. Following severe sepsis, septic shock or other shocks, combined with multiple organ failure, the ANR is an autonomous prognosis worsening factor.
Should the results of our study show a correlation between the production of HSP and the outcome of children with ANR, further studies would be required, to examine the pathophysiological relevance of HSP in ANR. We would then be able to determine a high risk population for ANR. A modulation of ANR therapy might be a result of further studies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Either severe sepsis, shock of any origin or asphyxia.
* Operated patients with operative or post-operative transfusion requirement of at least 0.5 x 80 ml/kg body weight of erythrocyte concentrate.
Exclusion Criteria
* Kidney transplantation.
* Missing written consent of the parents or guardian (if applicable).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ludwig-Maximilians - University of Munich
OTHER
University of Munich Children's Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
LMU Munich
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karl Reiter, Dr. med.
Role: STUDY_CHAIR
Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital
Judith Glöckner-Pagel, Dr. med.
Role: STUDY_DIRECTOR
Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital
Dennis A. Ballwieser, cand. med.
Role: PRINCIPAL_INVESTIGATOR
Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum Augsburg, II. Klinik für Kinder und Jugendliche
Augsburg, Bavaria, Germany
Kinderklinik Memmingen
Memmingen, Bavaria, Germany
Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital
Munich, Bavaria, Germany
Deutsches Herzzentrum München
Munich, Bavaria, Germany
Klinkum der Barmherzigen Brüder St. Hedwig
Regensburg, Bavaria, Germany
Kinderklinik Rosenheim
Rosenheim, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. 2005 Jan 29-Feb 4;365(9457):417-30. doi: 10.1016/S0140-6736(05)17831-3.
Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004 Jul 8;351(2):159-69. doi: 10.1056/NEJMra032401. No abstract available.
Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996 May 30;334(22):1448-60. doi: 10.1056/NEJM199605303342207. No abstract available.
Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002 Jan 31;346(5):305-10. doi: 10.1056/NEJMoa010877.
Related Links
Access external resources that provide additional context or updates about the study.
Dr. von Haunersches Kinderspital München/University of Munich Children's Clinic
Universität München/University of Munich
City of Augsburg Clinic
City of Rosenheim Clinic
The Brothers of Mercy's Hospital at Regensburg
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Projektnummer 233-05
Identifier Type: -
Identifier Source: secondary_id
HSP-233-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.